Skip to main content
. 2021 Jan;9(2):156. doi: 10.21037/atm-20-8052

Table 2. Genotypes of KCNQ1 and KCNQ1OT1 polymorphisms with clinical outcome of gastric cancer patients.

SNP ID Genotype Total/event OS Total/event RFS
Log-rank P MST HR (95% CI) P Log-rank P MST HR (95% CI) P
rs6578283 AA 421/140 62 0.804 421/179 41 0.503
GA 211/77 0.773 57 0.958 (0.696–1.32) 0.795 211/94 0.986 31 0.880 (0.660–1.174) 0.386
GG 32/9 47.3 1.234 (0.594–2.565) 0.573 32/14 29 1.223 (0.670–2.231) 0.512
Dominant 243/86 0.781 57 0.985 (0.725–1.339) 0.925 243/108 0.87 30 0.918 (0.699–1.207) 0.542
rs231348 CC 520/173 57 0.781 520/221 37 0.621
TC 131/48 0.766 57 1.001 (0.704–1.451) 0.953 131/59 0.343 32 0.996 (0.722–1.374) 0.981
TT 12/5 41.039 1.436 (0.524–3.937) 0.481 12/7 17 1.561 (0.635–3.836) 0.331
Dominant 143/53 0.754 57 1.040 (0.735–1.473) 0.824 143/66 0.675 29 1.032 (0.757–1.406) 0.842
rs760419 AA 304/105 62 0.174 304/131 31 0.302
GA 281/90 0.517 59 0.787 (0.565–1.096) 0.157 281/117 0.609 41 0.845 (0.632–1.128) 0.253
GG 79/31 39 1.165 (0.743–1.825) 0.507 79/39 22 1.127 (0.752–1.687) 0.563
Dominant 360/121 0.88 57 0.866 (0.638–1.176) 0.358 360/156 0.953 37 0.904 (0.690–1.183) 0.462
r231356 TT 406/138 57 0.827 406/172 40 0.358
TA 228/79 0.961 57 1.038 (0.758–1.421) 0.818 228/102 0.864 31 1.063 (0.806–1.403) 0.664
AA 30/9 46.776 1.289 (0.561–2.959) 0.55 30/12 26 1.637 (0.827–3.241) 0.157
Dominant 258/88 0.986 57 1.056 (0.778–1.433) 0.726 258/115 0.613 31 1.102 (0.843–1.441) 0.478
rs231354 CC 507/172 57 0.917 507/213 40 0.556
TC 150/52 0.961 57 1.043 (0.740–1.470) 0.812 150/71 0.636 29 1.150 (0.854–1.550) 0.356
TT 7/2 47.7 0.714 (0.099–5.167) 0.739 7/3 17 0.582 (0.081–4.193) 0.591
Dominant 157/54 0.925 57 1.032 (0.734–1.450) 0.858 157/74 0.342 29 1.132 (0.842–1.521) 0.413
rs231352 CC 509/172 57 0.914 509/214 40 0.545
TC 148/52 0.936 57 1.045 (0.741–1.473) 0.803 148/70 0.634 26 1.154 (0.857–1.555) 0.346
TT 7/2 47.7 0.714 (0.099–5.169) 0.739 7/3 17 0.582 (0.081–4.195) 0.591
Dominant 155/54 0.826 57 1.034 (0.736–1.453) 0.848 155/73 0.34 26 1.135 (0.844–1.526) 0.401
rs7939976 AA 550/193 57 0.014 550/243 32 0.010
GA 112/31 0.048 47.832 0.929 (0.595–1.449) 0.745 112/42 <0.001 11.258 1.030 (0.704–1.508) 0.878
GG 2/2 4 20.749 (2.680–160.616) 0.004 2/2 2 23.238 (3.026–178.479) 0.002
Dominant 114/33 0.263 47.06 0.972 (0.628–1.504) 0.897 114/44 0.322 40.59 1.063 (0.730–1.548) 0.750
rs10832514 AA 517/174 57 0.155 517/219 37 0.081
GA 139/49 0.809 41.823 1.359 (0.955–1.933) 0.088 139/64 0.812 29 1.346 (0.984–1.840) 0.063
GG 8/3 36.964 1.821 (0.574–5.783) 0.309 8/4 20 2.041 (0.750–5.558) 0.163
Dominant 147/52 0.517 41.778 1.383 (0.982–1.949) 0.064 147/68 0.522 29 1.379 (1.017–1.870) 0.039
rs231361 AA 409/142 57 0.975 409/179 35 0.608
GA 225/76 0.832 57 1.031 (0.752–1.413) 0.849 225/96 0.981 37 1.038 (0.787–1.371) 0.791
GG 29/8 48.286 1.066 (0.432–2.633) 0.89 29/12 38.76 1.437 (0.700–2.952) 0.323
Dominant 254/84 0.768 44.71 1.034 (0.761–1.405) 0.832 254/108 0.856 37 1.066 (0.814–1.395) 0.642
rs231359 AA 410/143 57 0.943 410/176 40 0.617
CA 224/75 0.788 57 0.950 (0.692–1.303) 0.749 224/99 0.986 31 1.029 (0.780–1.357) 0.840
CC 29/8 48.286 1.038 (0.420–2.562) 0.936 29/12 38.76 1.433 (0.698–2.945) 0.327
Dominant 253/83 0.611 45.069 0.956 (0.703–1.300) 0.775 253/111 0.865 31 1.056 (0.808–1.381) 0.690
rs7128926 AA 547/192 57 0.012 547/242 32 0.010
GA 115/32 0.05 47.667 0.863 (0.553–1.346) 0.515 115/43 <0.001 11.293 0.946 (0.647–1.385) 0.777
GG 2/2 4 20.585 (2.659–159.37) 0.004 2/2 2 22.981 (2.992–176.541) 0.003
Dominant 117/34 0.277 46.924 0.902 (0.583–1.395) 0.642 117/45 0.315 40.64 0.976 (0.670–1.421) 0.899

KCNQ1, potassium voltage-gated channel KQT-like subfamily member 1; OS, overall survival; RFS, recurrence-free survival; MST, median survival time;